Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Cash & Equivalents (2023 - 2025)

Wellgistics Health filings provide 3 years of Cash & Equivalents readings, the most recent being $42571.0 for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 95.86% to $42571.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $42571.0, a 95.86% decrease, with the full-year FY2025 number at $42571.0, down 95.86% from a year prior.
  • Cash & Equivalents hit $42571.0 in Q4 2025 for Wellgistics Health, down from $4.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.2 million in Q3 2025 to a low of $1364.0 in Q4 2023.
  • Median Cash & Equivalents over the past 3 years was $724139.0 (2024), compared with a mean of $1.4 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 75291.2% in 2024 and later crashed 95.86% in 2025.
  • Wellgistics Health's Cash & Equivalents stood at $1364.0 in 2023, then skyrocketed by 75291.2% to $1.0 million in 2024, then crashed by 95.86% to $42571.0 in 2025.
  • The last three reported values for Cash & Equivalents were $42571.0 (Q4 2025), $4.2 million (Q3 2025), and $419942.0 (Q2 2025) per Business Quant data.